SCHEMBL6535902

SCHEMBL6535902

COc1c(C(=O)O)ccc(-c2ccccc2)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HTT P42858 2/20 0.44
HNF4A P41235 1/20 0.44
ACLY P53396 1/20 0.44
CHEK1 O14757 1/20 0.44
IKBKB O14920 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
PDE4B Q07343 3/20 0.42
PDE4A P27815 2/20 0.42
PDE4C Q08493 2/20 0.42
PDE4D Q08499 2/20 0.42
FOLH1 Q04609 1/20 0.42
PTPN1 P18031 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
TUBB4A P04350 3/20 0.42
TUBB P07437 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28213739 0.88 HTT (0.47) SMN1; SMN2MAPTHTTCHEK1IKBKB
SCHEMBL29152929 0.86 CYP2C8 (0.52) SMN1; SMN2MAPTTDP1CHEK1FOLH1
SCHEMBL8197604 0.86 SMN1; SMN2 (0.45) SMN1; SMN2MAPTTDP1HTTHNF4A
SCHEMBL6535963 0.86 PDCD1 (0.49) MAPTHTTCHEK1NR1H4KDM4E
SCHEMBL14689569 0.86 MAPT (0.60) SMN1; SMN2MAPTTDP1HTTHNF4A
SCHEMBL7359467 0.86 HTT (0.43) SMN1; SMN2HTTACLYIKBKBNR1H4
SCHEMBL30719082 0.86 CYP2C8 (0.52) SMN1; SMN2MAPTTDP1CHEK1FOLH1
SCHEMBL4632581 0.86 HNF4A (0.58) SMN1; SMN2HTTHNF4AIKBKBNR1H4
SCHEMBL30394743 0.86 HNF4A (0.58) SMN1; SMN2HTTHNF4AIKBKBNR1H4
SCHEMBL17799595 0.84 HNF4A (0.56) SMN1; SMN2HTTHNF4AIKBKBNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425015-A4 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL MYERS SQUIBB CO (US) 2004-12-15 EP claimed
EP-1425015-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-09 EP claimed
WO-2003015715-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-02-27 WO claimed
CN-114773249-A Compounds, pharmaceutical compositions and methods for treating inflammatory diseases 艾匹克治疗公司 2022-07-22 CN disclosed
CN-101267811-B Novel multi-cyclic compounds and their use REVOTAR BIOPHARMACEUTICALS AG 2012-07-25 CN disclosed
EP-1425015-A4 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL MYERS SQUIBB CO (US) 2004-12-15 EP disclosed
EP-1425015-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-09 EP disclosed
WO-2003015715-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-02-27 WO disclosed
CN-1333766-A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors AVENTIS PHARM PROD INC (US) 2002-01-30 CN disclosed